WO1998053053A2 - Dna encoding an arthropod chitin synthase - Google Patents

Dna encoding an arthropod chitin synthase Download PDF

Info

Publication number
WO1998053053A2
WO1998053053A2 PCT/EP1998/002970 EP9802970W WO9853053A2 WO 1998053053 A2 WO1998053053 A2 WO 1998053053A2 EP 9802970 W EP9802970 W EP 9802970W WO 9853053 A2 WO9853053 A2 WO 9853053A2
Authority
WO
WIPO (PCT)
Prior art keywords
chitin
enzyme
dna
sequence
nucleic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP1998/002970
Other languages
French (fr)
Other versions
WO1998053053A3 (en
Inventor
George Thireos
Dimitris Kafetzopoulos
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Foundation For Research And Technology - Hellas (forth)
Original Assignee
Foundation For Research And Technology - Hellas (forth)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to DK98928300T priority Critical patent/DK0983366T3/en
Priority to EP98928300A priority patent/EP0983366B1/en
Priority to AT98928300T priority patent/ATE239082T1/en
Priority to JP54995498A priority patent/JP2001506138A/en
Priority to AU80190/98A priority patent/AU8019098A/en
Priority to US09/230,041 priority patent/US6465179B1/en
Application filed by Foundation For Research And Technology - Hellas (forth) filed Critical Foundation For Research And Technology - Hellas (forth)
Priority to DE69814067T priority patent/DE69814067T2/en
Publication of WO1998053053A2 publication Critical patent/WO1998053053A2/en
Priority to NO990244A priority patent/NO990244D0/en
Publication of WO1998053053A3 publication Critical patent/WO1998053053A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N61/00—Biocides, pest repellants or attractants, or plant growth regulators containing substances of unknown or undetermined composition, e.g. substances characterised only by the mode of action
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1048—Glycosyltransferases (2.4)
    • C12N9/1051—Hexosyltransferases (2.4.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y204/00—Glycosyltransferases (2.4)
    • C12Y204/01—Hexosyltransferases (2.4.1)
    • C12Y204/01016—Chitin synthase (2.4.1.16)

Definitions

  • the present invention relates to nucleic acids comprising a nucleotide sequence encoding at least a portion of an enzyme which catalyzes the synthesis of chitin in arthropods, inhibitors directed to said enzyme, and a method for developing said inhibitors.
  • Chitin is a carbohydrate homopolymer of ⁇ ( 1 - > 4) linked N-acetylglucosamine. Chitin is a structural polysaccharide occurring mainly in the cell wall of some fungi and in exoskeleton of the arthropods.
  • Chitin is synthesized by the action of specialized enzymes, referred to as chitin synthases, that catalyze the polymerization of N-acetylglucosaminyl residues into chitin from uridine 5'-diphospho-N-acetylglucosamine.
  • Chitin synthases belong to a group of enzymes that catalyze the synthesis of linear structural polysaccharides and are collectively termed as processive glycosyltransferases.
  • the primary structures of the known processive glycosyl transferases i.e. the fungal chitin synthases, the prokaryotic and eukaryotic cellulose synthases, the prokaryotic and eukaryotic hyaluronan synthases, the prokaryotic alginate synthases and the rhizobial chito-oligosaccharide synthases
  • the various processive glucosyltransferases display substantial differences mainly in their substrate specificities, their activation and inhibition parameters, the size and conformation of their products.
  • Known insect chitin synthesis inhibitors fall within two main categories: (a) direct inhibitors of chitin synthesis such as the Strepto- myces antibiotics Nikkomycins and Polyoxins and (b) insect growth regulators that interfere indirectly but drastically with the synthesis of chitin in insects, such us the benzoylphenyl-urea derivatives.
  • the technical problem underlying the present invention is to provide new inhibitors for the chitin synthesis in order to prevent damages caused by arthropods.
  • nucleic acid which comprises a nucleotide sequence encoding at least a portion of an enzyme which catalyzes the synthesis of chitin in arthropods.
  • nucleic acid and “nucleotide sequence” refer to endogenously expressed, semisynthetic, synthetic or chemically modified acid molecules of deoxyribonucleotides and/or ribonucleotides.
  • the nucleotide sequence include sequences as illustrated in Figures 1 (SEQ ID NO. 1 ), 2 (SEQ ID NO. 3), and 3 (SEQ ID NO. 5), allelic derivatives of said sequences and DN A-sequences degenerated as a result of the genetic code for said sequences. It also includes DNA sequences hybridizing under stringent conditions with the nucleotide sequence defined above.
  • allelic, degenerate and hybridising sequences may have structural divergences due to (naturally occurring) mutations, such as small deletions or substitutions, they will usually still exhibit essentially the same useful properties, allowing their use in basically the same applications.
  • the present invention relates to an isolated DNA sequence encoding a portion of an enzyme which catalyzes the synthesis of chitin in arthropods.
  • Specific embodiments include DNA sequences which are characterized by the ability to hybridize to the DNA sequence represented in Figure 1 at e.g. 55 °C or encode a polypeptide reactive with an antibody against the polypeptide containing the deduced amino acid sequence in figures 1 to 3.
  • the invention also relates to a DNA expression construct containing the isolated DNA sequences and encoding an enzyme having the specificity described above.
  • the present invention also relates to recombinant molecules comprising the nucleic acid as described above optionally linked to an expression-control sequence.
  • Such vectors may be useful in the production of at least said portion of an enzyme in stable or transiently transformed cells.
  • Several animal, plant, fungal and bacterial systems may be used for the transformation and subsequent cultivation process.
  • expression vectors which can be used in the invention contain sequences necessary for the replication in the host cell and are autonomously replicable. It is also preferable to use vectors containing selectable marker genes which can be easily selected for transformed ceils. The necessary preparation is well known to those skilled in the art.
  • suitable host cells include various eukaryotic and prokaryotic cells, such as E. coli. insect ceils, plant cells, mammalian cells, and fungi such as yeast.
  • Another object of the present invention is to provide a polypeptide comprising at least a portion of an enzyme which catalyzes the synthesis of chitin in arthro- pods.
  • polypeptide includes the complete enzyme or a biologically active or inactive fragment thereof encoded by the sequences described above and displaying preferably biologically features of said enzyme.
  • the amino acid sequences of specially preferred polypeptides contain the sequences displayed in Figures 1 (SEQ ID NO. 2), 2 (SEQ ID NO. 4) and 3 (SEQ ID NO. 6) . It is a further aspect of the invention to provide a process for the production of the above mentioned polypeptide.
  • Such a process comprises cultivating a host cell being transformed with a nucleic acid sequence of the present invention in a suitable culture medium and purifying the produced polypeptide.
  • the host cell is obtainable from bacteria such as E. coli, from fungi, such as yeast, from plants such as tobacco, potato, or Arabidopsis. and from animals, in particular vertebrate cells such as the CHO-cells.
  • the invention also relates to the methods for assaying the effects of various compounds on the expression and the biological activity of arthropod chitin synthases.
  • the polypeptide in enzymatically active form, preferably the enzyme chitin synthase of an arthropod is produced by recombinant DNA techniques in which an isolated DNA sequence encoding the enzyme is expressed from a DNA expression construct as outlined above.
  • Figures 1 to 3 show DNA sequences (SEQ ID NOs. 1 , 3 and 5) and the deduced amino acid sequences (SEQ ID NOs. 2, 4 and 6) of a portion of chitin synthase of Drosophila melanoqaster.
  • Figures 4 and 5 show multiple protein sequence alignments of the portion of chitin synthase of Drosophila melanoqaster with the corresponding regions of a nematode, three yeast chitin synthases and a rhizobial chito-oligosaccharide synthase.
  • the multiple sequence alignments show the isolated portion of Drosophila melanoqaster chitin synthase (Dmechsl in Figure 4, and Dmechs2 in Figure 5) with the corresponding regions of the nematode chitin synthase (Celchs), the chitin synthase 1 (Scechsl ), the chitin synthase 2 (Scechs2) and chitin synthase 3 (Scechs3) of yeast and the rhizobial chito-oligosaccharide synthase (RlenodC) .
  • the dots above the alignment indicate similarity and the asterisks identity. In the following preferred embodiments of the present invention are outlined in more detail.
  • Drosophila melanoqaster (fruitfly), recombinant methodology for the expression, purification and identification of chitin synthases can be used. These methods employed in assays for the evaluation and characterization of insect chitin synthase inhibitors can lead to the development of new potent pest control agents.
  • the present invention was made possible with identification of the DNA sequence shown in Figures 1 to 3, encoding for a portion of chitin synthase of Drosophila melanoqaster.
  • a search of the GENBANK databank using the deduced amino acid sequence of Drosophila melanoqaster sequence revealed significant similarities with a nematode sequence presumably encoding for a chitin synthase, with several sequences encoding for fungal chitin synthases, and with several rhizobial chito-oligo- saccharide synthases.
  • the multiple sequence alignments of the Drosophila melanoqaster chitin synthase with these sequences are presented in Figures 4 and 5.
  • hybridization, immunochemical or polymerase chain reaction amplification methods can be used for the isolation of either cDNA or genomic DNA of chitin synthase from this species.
  • the same approaches can be used for the identification and isolation of DNA encoding the chitin synthases of other arthropod species.
  • the isolated DNA sequences which fall within the scope of this invention can be used to express the encoded chitin synthases in large quantities in either prokaryotic or eukaryotic host cell.
  • the invention relates to methods for developing pest control agents.
  • Chitin synthases of arthropods can be produced by recombinant DNA methodology as outlined above and used in enzyme assays for the evaluation and characterization of specific chitin synthase inhibitors. These preparations can also be used in the screening for the identification of new chitin synthesis inhibitors.
  • DNA constructs of the arthropod chitin synthases fused with reporter genes can be used to obtain trangenic insects or tra ⁇ for- med cell lines as outlined above. These animals and cell lines can be used in the evaluation of effect insect growth regulators have in the biosynthesis of chitin.
  • a DNA fragment containing the isolated DNA sequence and encoding for the insect chitin synthase is inserted in an expression vector containing a lac induci- ble promoter.
  • the construct is used to transform E. coli cells. Cells are grown in LB medium at half-log phase and the expression of chitin synthase is induced by the addition of 1 mM IPTG.
  • the cell After 4 hours the cell are harvested by centrifugation and lysed by sonication. The homogenate is centrifuged at 2000 g for 30 minutes at 4°C and the supernatant of the centrifugation is ultracentrifuged at 100 000 g for one hour. The pellet containing the membrane fraction were resuspended in a buffer containing 25 mM Tris HCI pH 7.0 and 10 mM Magnesium chloride. This membrane preparation is subsequently used in chitin synthase inhibition assays.
  • the assays are performed by incubating a sample of the membrane fraction with
  • UDP-GlcNAc 5mM and the compounds tested for chitin synthesis inhibition The activity of chitin synthase is evaluated by either the measurement of incorporation of radiolabelled GlcNAc from UDP-GlcNAc into chitin or by the spectropho- tometric estimation of released UDP by the method of the coupled enzyme reactions assay. Comparison of the measured activity to that obtained under control conditions (no compound added) is used for the evaluation of compounds as a chitin synthase inhibitor.
  • a DNA fragment encoding the promoter and a portion of the coding regions of the insect chitin synthase is fused to lacZ reporter gene.
  • the DNA construct containing the translational fusion of Chitin synthase-lacZ is used for the transformation of Kc insect cells. After the selection and isolation of stable tranfor- mants the transformed cell line is used for the testing or screening for compound that affect the transcriptional activation of the chitin synthase gene.
  • the cell line is incubated with the compounds for 24 hours and the effect of the compo u nds is eva luated by measu ri n g and co mpa ri n g the beta-galactosidase activity to that of the control.
  • Radioactive DNA probes generated by this method are used for the identification and isolation of clones encoding for chitin synthases from a genomic DNA cosmid library of C ⁇ melanoqaster.
  • the DNA of the recombinant cosmids is placed (blotted) on nitrocellulose filters, denatured and thin hybridized with the radioactive DNA probe. Hybridisation is performed at low stringency conditions (0.75M [Na + ], 55 °C) . Filters are then washed and exposed for autoradiography.
  • Cosmids which hybridized with the probe are isolated and further characterized with restriction enzyme analysis and DNA sequence analysis.
  • Figure 5 shows multiple protein sequence alignment of the portion of Dmechs2 with the corresponding regions of a nematode, three yeast chitin synthases and a rhizobial chito-oligosaccharide synthase.

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pest Control & Pesticides (AREA)
  • Dentistry (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Agronomy & Crop Science (AREA)
  • Analytical Chemistry (AREA)
  • Plant Pathology (AREA)
  • Immunology (AREA)
  • Environmental Sciences (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The present invention relates to nucleic acids comprising a nucleotide sequence encoding at least a portion of an enzyme which catalyzes the synthesis of chitin in arthropods, a screening to assay and identify new, and method for developing chitin synthesis inhibitors.

Description

DNA ENCODING AN ARTHROPOD CHITIN SYNTHASE
The present invention relates to nucleic acids comprising a nucleotide sequence encoding at least a portion of an enzyme which catalyzes the synthesis of chitin in arthropods, inhibitors directed to said enzyme, and a method for developing said inhibitors.
Chitin is a carbohydrate homopolymer of β( 1 - > 4) linked N-acetylglucosamine. Chitin is a structural polysaccharide occurring mainly in the cell wall of some fungi and in exoskeleton of the arthropods.
Chitin is synthesized by the action of specialized enzymes, referred to as chitin synthases, that catalyze the polymerization of N-acetylglucosaminyl residues into chitin from uridine 5'-diphospho-N-acetylglucosamine.
Chitin synthases belong to a group of enzymes that catalyze the synthesis of linear structural polysaccharides and are collectively termed as processive glycosyltransferases. The primary structures of the known processive glycosyl transferases (i.e. the fungal chitin synthases, the prokaryotic and eukaryotic cellulose synthases, the prokaryotic and eukaryotic hyaluronan synthases, the prokaryotic alginate synthases and the rhizobial chito-oligosaccharide synthases) present some sequence similarities suggesting that these UDP-sugar utilizing enzymes show a similar mode of action. Despite the similarities, the various processive glucosyltransferases display substantial differences mainly in their substrate specificities, their activation and inhibition parameters, the size and conformation of their products.
Since several arthropod species are considered as plant and animal pests, the inhibition of the chitin synthesis machinery has been viewed in particular as an attractive target for the development of pest control agent.
Known insect chitin synthesis inhibitors, either natural or synthetic, fall within two main categories: (a) direct inhibitors of chitin synthesis such as the Strepto- myces antibiotics Nikkomycins and Polyoxins and (b) insect growth regulators that interfere indirectly but drastically with the synthesis of chitin in insects, such us the benzoylphenyl-urea derivatives.
Although the studies for the identification of these compounds have a history of several decades, the action of chitin synthesis inhibitors is still inadequately understood. This is due to both the limited availability of suitable insect chitin synthase enzyme preparations and to the lack of any molecular insight on the chitin synthesis and its regulation in insects.
Thus, the technical problem underlying the present invention is to provide new inhibitors for the chitin synthesis in order to prevent damages caused by arthropods.
The solution to the above technical problem is achieved by providing the embo- diments characterized in the claims.
In particular, there is provided a nucleic acid which comprises a nucleotide sequence encoding at least a portion of an enzyme which catalyzes the synthesis of chitin in arthropods.
The terms "nucleic acid" and "nucleotide sequence" refer to endogenously expressed, semisynthetic, synthetic or chemically modified acid molecules of deoxyribonucleotides and/or ribonucleotides. In a preferred embodiment of the present invention the nucleotide sequence include sequences as illustrated in Figures 1 (SEQ ID NO. 1 ), 2 (SEQ ID NO. 3), and 3 (SEQ ID NO. 5), allelic derivatives of said sequences and DN A-sequences degenerated as a result of the genetic code for said sequences. It also includes DNA sequences hybridizing under stringent conditions with the nucleotide sequence defined above. Although said allelic, degenerate and hybridising sequences may have structural divergences due to (naturally occurring) mutations, such as small deletions or substitutions, they will usually still exhibit essentially the same useful properties, allowing their use in basically the same applications.
In a preferred embodiment the present invention relates to an isolated DNA sequence encoding a portion of an enzyme which catalyzes the synthesis of chitin in arthropods. Specific embodiments include DNA sequences which are characterized by the ability to hybridize to the DNA sequence represented in Figure 1 at e.g. 55 °C or encode a polypeptide reactive with an antibody against the polypeptide containing the deduced amino acid sequence in figures 1 to 3. The invention also relates to a DNA expression construct containing the isolated DNA sequences and encoding an enzyme having the specificity described above.
The present invention also relates to recombinant molecules comprising the nucleic acid as described above optionally linked to an expression-control sequence. Such vectors may be useful in the production of at least said portion of an enzyme in stable or transiently transformed cells. Several animal, plant, fungal and bacterial systems may be used for the transformation and subsequent cultivation process. Preferably, expression vectors which can be used in the invention contain sequences necessary for the replication in the host cell and are autonomously replicable. It is also preferable to use vectors containing selectable marker genes which can be easily selected for transformed ceils. The necessary preparation is well known to those skilled in the art.
It is another object of the invention to provide a host cell transformed by an expression plasmid of the invention and capable of producing at least said portion of an enzyme. Examples of suitable host cells include various eukaryotic and prokaryotic cells, such as E. coli. insect ceils, plant cells, mammalian cells, and fungi such as yeast.
Another object of the present invention is to provide a polypeptide comprising at least a portion of an enzyme which catalyzes the synthesis of chitin in arthro- pods. The term "polypeptide" includes the complete enzyme or a biologically active or inactive fragment thereof encoded by the sequences described above and displaying preferably biologically features of said enzyme. The amino acid sequences of specially preferred polypeptides contain the sequences displayed in Figures 1 (SEQ ID NO. 2), 2 (SEQ ID NO. 4) and 3 (SEQ ID NO. 6) . It is a further aspect of the invention to provide a process for the production of the above mentioned polypeptide. Such a process comprises cultivating a host cell being transformed with a nucleic acid sequence of the present invention in a suitable culture medium and purifying the produced polypeptide. Thus, this process allows the production of the sufficient amount of the desired polypeptide for use in applications described herein below. The host cell is obtainable from bacteria such as E. coli, from fungi, such as yeast, from plants such as tobacco, potato, or Arabidopsis. and from animals, in particular vertebrate cells such as the CHO-cells.
The invention also relates to the methods for assaying the effects of various compounds on the expression and the biological activity of arthropod chitin synthases. In these methods the polypeptide in enzymatically active form, preferably the enzyme chitin synthase of an arthropod is produced by recombinant DNA techniques in which an isolated DNA sequence encoding the enzyme is expressed from a DNA expression construct as outlined above.
The figures show:
Figures 1 to 3 show DNA sequences (SEQ ID NOs. 1 , 3 and 5) and the deduced amino acid sequences (SEQ ID NOs. 2, 4 and 6) of a portion of chitin synthase of Drosophila melanoqaster.
Figures 4 and 5 show multiple protein sequence alignments of the portion of chitin synthase of Drosophila melanoqaster with the corresponding regions of a nematode, three yeast chitin synthases and a rhizobial chito-oligosaccharide synthase. In particular, the multiple sequence alignments show the isolated portion of Drosophila melanoqaster chitin synthase (Dmechsl in Figure 4, and Dmechs2 in Figure 5) with the corresponding regions of the nematode chitin synthase (Celchs), the chitin synthase 1 (Scechsl ), the chitin synthase 2 (Scechs2) and chitin synthase 3 (Scechs3) of yeast and the rhizobial chito-oligosaccharide synthase (RlenodC) . The dots above the alignment indicate similarity and the asterisks identity. In the following preferred embodiments of the present invention are outlined in more detail.
With the isolation of the first insect chitin synthase disclosed here, that of
Drosophila melanoqaster (fruitfly), recombinant methodology for the expression, purification and identification of chitin synthases can be used. These methods employed in assays for the evaluation and characterization of insect chitin synthase inhibitors can lead to the development of new potent pest control agents.
The present invention was made possible with identification of the DNA sequence shown in Figures 1 to 3, encoding for a portion of chitin synthase of Drosophila melanoqaster.
A search of the GENBANK databank using the deduced amino acid sequence of Drosophila melanoqaster sequence revealed significant similarities with a nematode sequence presumably encoding for a chitin synthase, with several sequences encoding for fungal chitin synthases, and with several rhizobial chito-oligo- saccharide synthases. The multiple sequence alignments of the Drosophila melanoqaster chitin synthase with these sequences are presented in Figures 4 and 5.
Despite the sequence similarities of the Drosophila melanoqaster chitin synthase with above described enzymes, hybridization of the Drosophila melanoqaster
DNA to neither the nematode nor the fungal genomic DNA could be observed even at low stringency conditions (0.75M [Na+], 55 °C).
With the isolation of the new insect chitin synthase gene, that of D. melano- aster, the use of recombinant methodology in the production, characterization and identification of arthropod chitin synthases can be employed .
By reference to the DNA sequence listed below, hybridization, immunochemical or polymerase chain reaction amplification methods can be used for the isolation of either cDNA or genomic DNA of chitin synthase from this species. The same approaches can be used for the identification and isolation of DNA encoding the chitin synthases of other arthropod species.
The isolated DNA sequences which fall within the scope of this invention can be used to express the encoded chitin synthases in large quantities in either prokaryotic or eukaryotic host cell.
In another aspect, the invention relates to methods for developing pest control agents. Chitin synthases of arthropods can be produced by recombinant DNA methodology as outlined above and used in enzyme assays for the evaluation and characterization of specific chitin synthase inhibitors. These preparations can also be used in the screening for the identification of new chitin synthesis inhibitors.
Further, DNA constructs of the arthropod chitin synthases fused with reporter genes (lacZ, GFP, luciferase) can be used to obtain trangenic insects or traπfor- med cell lines as outlined above. These animals and cell lines can be used in the evaluation of effect insect growth regulators have in the biosynthesis of chitin.
The present invention will be further illustrated by the following examples.
EXAMPLE 1
A DNA fragment containing the isolated DNA sequence and encoding for the insect chitin synthase is inserted in an expression vector containing a lac induci- ble promoter. The construct is used to transform E. coli cells. Cells are grown in LB medium at half-log phase and the expression of chitin synthase is induced by the addition of 1 mM IPTG.
After 4 hours the cell are harvested by centrifugation and lysed by sonication. The homogenate is centrifuged at 2000 g for 30 minutes at 4°C and the supernatant of the centrifugation is ultracentrifuged at 100 000 g for one hour. The pellet containing the membrane fraction were resuspended in a buffer containing 25 mM Tris HCI pH 7.0 and 10 mM Magnesium chloride. This membrane preparation is subsequently used in chitin synthase inhibition assays.
The assays are performed by incubating a sample of the membrane fraction with
UDP-GlcNAc 5mM and the compounds tested for chitin synthesis inhibition. The activity of chitin synthase is evaluated by either the measurement of incorporation of radiolabelled GlcNAc from UDP-GlcNAc into chitin or by the spectropho- tometric estimation of released UDP by the method of the coupled enzyme reactions assay. Comparison of the measured activity to that obtained under control conditions (no compound added) is used for the evaluation of compounds as a chitin synthase inhibitor.
EXAMPLE 2
A DNA fragment encoding the promoter and a portion of the coding regions of the insect chitin synthase is fused to lacZ reporter gene. The DNA construct containing the translational fusion of Chitin synthase-lacZ is used for the transformation of Kc insect cells. After the selection and isolation of stable tranfor- mants the transformed cell line is used for the testing or screening for compound that affect the transcriptional activation of the chitin synthase gene. In these assays the cell line is incubated with the compounds for 24 hours and the effect of the compo u nds is eva luated by measu ri n g and co mpa ri n g the beta-galactosidase activity to that of the control.
EXAMPLE 3
100 ng of the DNA fragment, encoding the sequence presented in Figure 2, is used for the incorporation of radioactive nucleotides into the double-stranded DNA according the standard "nick translation" methodology. Radioactive DNA probes generated by this method are used for the identification and isolation of clones encoding for chitin synthases from a genomic DNA cosmid library of Cλ melanoqaster. The DNA of the recombinant cosmids is placed (blotted) on nitrocellulose filters, denatured and thin hybridized with the radioactive DNA probe. Hybridisation is performed at low stringency conditions (0.75M [Na + ], 55 °C) . Filters are then washed and exposed for autoradiography.
Cosmids which hybridized with the probe (positive clones), are isolated and further characterized with restriction enzyme analysis and DNA sequence analysis.
From the procedure described above a second gene (Dmechs2) encoding for chitin synthase in this species is identified and partially sequences. The DNA sequence and the deduced amino acid sequence are presented in Figure 3.
Figure 5 shows multiple protein sequence alignment of the portion of Dmechs2 with the corresponding regions of a nematode, three yeast chitin synthases and a rhizobial chito-oligosaccharide synthase.

Claims

Claims
1 . A nucleic acid which comprises a nucleotide sequence encoding at least a portion of an enzyme which catalyzes the synthesis of chitin in ar- thropods.
2. The nucleic acid according to claim 1 , wherein the nucleotide sequence contains the DNA sequence as shown in SEQ ID NOs. 1 , 3 or 5.
3. A recombinant molecule comprising a nucleic acid according to claim 1 or
2.
4. The recombinant molecule according to claim 3, wherein said nucleic acid sequence is functionally linked to an expression-control sequence.
5. A host containing the nucleic acid according to claim 1 or 2, or the recombinant molecule according to claim 3 or 4.
6. A polypeptide comprising at least a portion of an enzyme which catalyzes the synthesis of chitin in arthropods.
7. The polypeptide according to claim 6, wherein the portion contains the amino acid sequence as shown in SEQ ID NOs. 2, 4 or 6.
8. An inhibitor directed to at least the portion as defined in claims 6 or 7.
9. The inhibitor according to claim 8, which is directed to chitin synthase of arthropods.
10. A method for developing chitin synthetase inhibitors, comprising the steps of
(a) producing a polypeptide as defined in claims 6 or 7 using recombinant DNA technology, and
(b) characterizing specific chitin synthese inhibitors in enzyme assays.
PCT/EP1998/002970 1997-05-21 1998-05-20 Dna encoding an arthropod chitin synthase Ceased WO1998053053A2 (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
EP98928300A EP0983366B1 (en) 1997-05-21 1998-05-20 Dna encoding an arthropod chitin synthase
AT98928300T ATE239082T1 (en) 1997-05-21 1998-05-20 DNA CODING FOR A CHITIN SYNTHASE FROM ARTHROPODS
JP54995498A JP2001506138A (en) 1997-05-21 1998-05-20 DNA encoding arthropod chitin synthase
AU80190/98A AU8019098A (en) 1997-05-21 1998-05-20 Dna encoding an arthropod chitin synthase
US09/230,041 US6465179B1 (en) 1997-05-21 1998-05-20 DNA encoding an arthropod chitin synthase
DK98928300T DK0983366T3 (en) 1997-05-21 1998-05-20 DNA encoding chitin synthase in arthropods
DE69814067T DE69814067T2 (en) 1997-05-21 1998-05-20 DNA WHICH CODES A CHITINE SYNTHASE FROM ARTHROPODES
NO990244A NO990244D0 (en) 1997-05-21 1999-01-20 DNA encoding an arthropod chitin synthase

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP97108240 1997-05-21
EP97108240.9 1997-05-21

Related Child Applications (2)

Application Number Title Priority Date Filing Date
US09/230,041 A-371-Of-International US6465179B1 (en) 1997-05-21 1998-05-20 DNA encoding an arthropod chitin synthase
US10/179,382 Division US20030166235A1 (en) 1997-05-21 2002-06-26 DNA encoding an arthropod chitin synthase

Publications (2)

Publication Number Publication Date
WO1998053053A2 true WO1998053053A2 (en) 1998-11-26
WO1998053053A3 WO1998053053A3 (en) 1999-03-18

Family

ID=8226808

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP1998/002970 Ceased WO1998053053A2 (en) 1997-05-21 1998-05-20 Dna encoding an arthropod chitin synthase

Country Status (11)

Country Link
US (2) US6465179B1 (en)
EP (2) EP1325954A1 (en)
JP (1) JP2001506138A (en)
AT (1) ATE239082T1 (en)
AU (1) AU8019098A (en)
DE (1) DE69814067T2 (en)
DK (1) DK0983366T3 (en)
ES (1) ES2198718T3 (en)
NO (1) NO990244D0 (en)
PT (1) PT983366E (en)
WO (1) WO1998053053A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050042735A1 (en) * 2003-04-11 2005-02-24 Ming-De Deng Metabolic engineering for enhanced production of chitin and chitosan in microorganisms
JP2005215892A (en) * 2004-01-28 2005-08-11 Canon Inc Authentication system, control method thereof, program, and storage medium

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69421644T2 (en) * 1993-05-25 2000-03-09 American Cyanamid Co. Calcofluor screening of chitin biosynthesis inhibitors
US5614377A (en) * 1994-02-28 1997-03-25 Myco Pharmaceuticals, Incorporated Methods for identifying inhibitors of fungal pathogenicity
US5824545A (en) * 1995-11-01 1998-10-20 Millennium Pharaceuticals, Inc. Identification of eukaryotic growth-related genes and promoter isolation vector and method of use

Also Published As

Publication number Publication date
AU8019098A (en) 1998-12-11
NO990244L (en) 1999-01-20
JP2001506138A (en) 2001-05-15
DE69814067T2 (en) 2004-04-08
PT983366E (en) 2003-08-29
ES2198718T3 (en) 2004-02-01
US6465179B1 (en) 2002-10-15
ATE239082T1 (en) 2003-05-15
WO1998053053A3 (en) 1999-03-18
NO990244D0 (en) 1999-01-20
EP0983366A2 (en) 2000-03-08
US20030166235A1 (en) 2003-09-04
EP0983366B1 (en) 2003-05-02
EP1325954A1 (en) 2003-07-09
DE69814067D1 (en) 2003-06-05
DK0983366T3 (en) 2003-07-28

Similar Documents

Publication Publication Date Title
Sachs et al. Anaerobic gene expression and flooding tolerance in maize
Saxena et al. Cellulose synthases and related enzymes
Qu et al. Identification of a novel group of putative Arabidopsis thaliana β-(1, 3)-galactosyltransferases
Fernandez et al. A new stress protein: synthesis of Schizosaccharomyces pombe UDP–Glc: glycoprotein glucosyltransferase mRNA is induced by stress conditions but the enzyme is not essential for cell viability.
Wolf-Dieter The molecular analysis of cell wall components
Pooley et al. A conditional-lethal mutant of Bacillus subtilis 168 with a thermosensitive glycerol-3-phosphate cytidylyltransferase, an enzyme specific for the synthesis of the major wall teichoic acid
Park et al. Molecular cloning and characterization of four cDNAs encoding the isoforms of NAD-dependent sorbitol dehydrogenase from the Fuji apple
EP2652130B1 (en) Trehalose phosphorylases and their use in the biocatalytic production of trehalose-analogues and glycosyl phosphates
Seibold et al. The glgX gene product of Corynebacterium glutamicum is required for glycogen degradation and for fast adaptation to hyperosmotic stress
Salamone et al. Isolation and characterization of a higher plant ADP-glucose pyrophosphorylase small subunit homotetramer
Reiter Arabidopsis thaliana as a model system to study synthesis, structure, and function of the plant cell wall
McGrath et al. In vitro detection and characterisation of a polyphosphate synthesising activity in the yeast Candida humicola G-1
JP4702819B2 (en) Chondroitin synthase
EP0983366B1 (en) Dna encoding an arthropod chitin synthase
Bloemberg et al. Substrate specificity and kinetic studies of nodulation protein NodL of Rhizobium leguminosarum
Mariette et al. Plant cell wall glycosyltransferases: from sequence to structure and function
CN102816783A (en) Integration of genes into the chromosome of saccharopolyspora spinosa
WO2003102194A1 (en) Chondroitin synthetase and dna coding for the enzyme
Hancock The Biosynthesis of Wall Teichoic Acid by Toluenised Cells of Bhacillus subtilis W23
WO2003102193A1 (en) Chondroitin synthetase and nucleic acid coding for the enzyme
Namekawa et al. DNA ligase IV from a basidiomycete, Coprinus cinereus, and its expression during meiosis
EP1072684A1 (en) Genes encoding proteins having activity of transferring sugar onto aurone
US20030022342A1 (en) Inositolphosphoryl ceramide (IPC) synthase genes from fungi
Koo et al. Cloning, sequencing, and expression of UDP-glucose pyrophosphorylase gene from Acetobacter xylinum BRC5
CN115109762B (en) A galactosyltransferase related to the biosynthesis of flavonol 3-O-galactoside and its application

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH GM GW HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG

WWE Wipo information: entry into national phase

Ref document number: 1998928300

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 09230041

Country of ref document: US

ENP Entry into the national phase

Ref country code: JP

Ref document number: 1998 549954

Kind code of ref document: A

Format of ref document f/p: F

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)

Free format text: (EXCEPT JP, NO, US, EP (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE))

AK Designated states

Kind code of ref document: A3

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH GM GW HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWP Wipo information: published in national office

Ref document number: 1998928300

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

NENP Non-entry into the national phase

Ref country code: CA

WWG Wipo information: grant in national office

Ref document number: 1998928300

Country of ref document: EP